AIM: To assess the prevalence and location of advanced neoplasia in patients undergoing colonoscopy, and to compare the yield per indication. METHODS: In a multicenter colonoscopy survey (n = 18 hospitals) in the Amsterdam area (Northern Holland), data of all colonoscopies performed during a three month period in 2005 were analyzed. The location and the histological features of all colonic neoplasia were recorded. The prevalence and the distribution of advanced colorectal neoplasia and differences in yield between indication clusters were evaluated. Advanced neoplasm was defined as adenoma > 10 mm in size, with > 25% villous features or with high-grade dysplasia or cancer. RESULTS: A total of 4623 eligible patients underwent a total colonoscopy. The prevalence of advanced neoplasia was 13%, with 281 (6%) adenocarcinomas and 342 (7%) advanced adenomas. Sixty-seven percent and 33% of advanced neoplasia were located in the distal and proximal colon, respectively. Of all patients with right-sided advanced neoplasia (n = 228), 51% had a normal distal colon, whereas 27% had a synchronous distal adenoma. Ten percent of all colonoscopies were performed in asymptomatic patients, 7% of whom had advanced neoplasia. In the respective procedure indication clusters, the prevalence of right-sided advanced neoplasia ranged from 11%-57%. CONCLUSION: One out of every 7-8 colonoscopies yielded an advanced colorectal neoplasm. Colonoscopy is warranted for the evaluation of both symptomatic and asymptomatic patients.
AIM: To assess the prevalence and location of advanced neoplasia in patients undergoing colonoscopy, and to compare the yield per indication. METHODS: In a multicenter colonoscopy survey (n = 18 hospitals) in the Amsterdam area (Northern Holland), data of all colonoscopies performed during a three month period in 2005 were analyzed. The location and the histological features of all colonic neoplasia were recorded. The prevalence and the distribution of advanced colorectal neoplasia and differences in yield between indication clusters were evaluated. Advanced neoplasm was defined as adenoma > 10 mm in size, with > 25% villous features or with high-grade dysplasia or cancer. RESULTS: A total of 4623 eligible patients underwent a total colonoscopy. The prevalence of advanced neoplasia was 13%, with 281 (6%) adenocarcinomas and 342 (7%) advanced adenomas. Sixty-seven percent and 33% of advanced neoplasia were located in the distal and proximal colon, respectively. Of all patients with right-sided advanced neoplasia (n = 228), 51% had a normal distal colon, whereas 27% had a synchronous distal adenoma. Ten percent of all colonoscopies were performed in asymptomatic patients, 7% of whom had advanced neoplasia. In the respective procedure indication clusters, the prevalence of right-sided advanced neoplasia ranged from 11%-57%. CONCLUSION: One out of every 7-8 colonoscopies yielded an advanced colorectal neoplasm. Colonoscopy is warranted for the evaluation of both symptomatic and asymptomatic patients.
Authors: Joseph J Y Sung; Francis K L Chan; Wai K Leung; Justin C Y Wu; James Y W Lau; Jessica Ching; Ka F To; Yuk T Lee; Yiu W Luk; Nelson N S Kung; Samuel P Y Kwok; Michael K W Li; S C Sydney Chung Journal: Gastroenterology Date: 2003-03 Impact factor: 22.682
Authors: Mary Beth Terry; Alfred I Neugut; Roberd M Bostick; John D Potter; Robert W Haile; Cecilia M Fenoglio-Preiser Journal: Cancer Epidemiol Biomarkers Prev Date: 2002-07 Impact factor: 4.254
Authors: Thomas F Imperiale; David R Wagner; Ching Y Lin; Gregory N Larkin; James D Rogge; David F Ransohoff Journal: Ann Intern Med Date: 2003-12-16 Impact factor: 25.391
Authors: Joseph C Anderson; Zvi Alpern; Catherine R Messina; Bernard Lane; Patricia Hubbard; Roger Grimson; Peter F Ells; Douglas L Brand Journal: Am J Gastroenterol Date: 2004-03 Impact factor: 10.864
Authors: M Bretthauer; G Gondal; K Larsen; E Carlsen; T J Eide; T Grotmol; E Skovlund; K M Tveit; M H Vatn; G Hoff Journal: Scand J Gastroenterol Date: 2002-05 Impact factor: 2.423
Authors: Aleksandra M Urbanska; Emmanouil D Karagiannis; Gonzalo Guajardo; Robert S Langer; Daniel G Anderson Journal: Biomaterials Date: 2012-04-01 Impact factor: 12.479
Authors: Chris Jacob Johan Mulder; Marc Peeters; Annemieke Cats; Anna Dahele; Jochim Terhaar sive Droste Journal: World J Gastroenterol Date: 2011-03-07 Impact factor: 5.742
Authors: Vicent Hernandez; Joaquin Cubiella; M Carmen Gonzalez-Mao; Felipe Iglesias; Concepción Rivera; M Begoña Iglesias; Lucía Cid; Ines Castro; Luisa de Castro; Pablo Vega; Jose Antonio Hermo; Ramiro Macenlle; Alfonso Martínez-Turnes; David Martínez-Ares; Pamela Estevez; Estela Cid; M Carmen Vidal; Angeles López-Martínez; Elisabeth Hijona; Marta Herreros-Villanueva; Luis Bujanda; Jose Ignacio Rodriguez-Prada Journal: World J Gastroenterol Date: 2014-01-28 Impact factor: 5.742
Authors: Jochim S Terhaar sive Droste; Frank A Oort; René W M van der Hulst; Veerle M H Coupé; Mike E Craanen; Gerrit A Meijer; Linde M Morsink; Otto Visser; Roy L J van Wanrooij; Chris J J Mulder Journal: BMC Cancer Date: 2010-06-28 Impact factor: 4.430
Authors: Jochim S Terhaar sive Droste; Sietze T van Turenhout; Frank A Oort; René W M van der Hulst; Vincent A Steeman; Usha Coblijn; Lisette van der Eem; Ruud Duijkers; Anneke A Bouman; Gerrit A Meijer; Annekatrien C T M Depla; Pieter Scholten; Ruud J L F Loffeld; Veerle M H Coupé; Chris J J Mulder Journal: BMC Gastroenterol Date: 2012-07-24 Impact factor: 3.067
Authors: Sietze T van Turenhout; Jochim S Terhaar sive Droste; Gerrit A Meijer; Ad A Masclée; Chris J J Mulder Journal: BMC Cancer Date: 2012-01-26 Impact factor: 4.430